Inappropriate Use of Antipsychotics as Nursing Home Chemical Restraints to Be Investigated By CMS
Federal regulators have announced a new investigation into the nationwide use of antipsychotics as chemical restraints in nursing homes.
Federal regulators have announced a new investigation into the nationwide use of antipsychotics as chemical restraints in nursing homes.
Federal investigators have issued a report raising concerns about new drugs potentially being used a "chemical restraints" in order to avoid detection and allegations of nursing home abuse.
A new study suggests anti-seizure medications like Depakote and Neurontin are being used to replace antipsychotics as "chemical restraints" on nursing home dementia patients.
While many nursing homes have shifted away from giving dementia patients antipsychotic "chemical restraints", a new study reveals they have turned to other drugs which also may not provide benefits…
A lawsuit filed against a Florida assisted living facility indicates it gave an elderly resident multiple doses of the antipsychotic Invega, despite express warnings not to give the drug to…
Federal inspectors have launched three investigations into potential nursing home neglect and abuse this month, with two focused on the response to COVID-19, and another into the use of psychotropic…
A new study finds that FDA warnings reduced the use of antipsychotics as chemical restraints on elderly nursing home residents, but in many cases, the facilities may have switched to…
A new study finds that dementia patients treated at home may be more prone to injury and to suffer from unmet medical needs.
A new study warns that giving dementia patients trazodone could be as risky as giving them atypical antipsychotics.
Federal investigators report that a third of foster care children in the U.S. prescribed psychotropic drugs are given no treatment plan or medical monitoring while taking the powerful medications.